By Connor Hart
Two Danaher subsidiaries have formed what the company called an investment partnership with Innovaccer, a healthcare artificial-intelligence company.
The partnership aims to improve patient outcomes and experiences through novel digital and diagnostic solutions, the companies said Thursday. It will additionally seek to accelerate the adoption of precision diagnostics by clinicians and population health teams.
Terms of the partnership weren't disclosed.
Innovaccer builds software that creates a unified patient record, which the company said allows it to use AI to identify gaps in care and patients who are at risk, as well as appropriate interventions to improve outcomes.
Washington, D.C.-based Danaher said the investment aligns with its mission to accelerate the transition to precision medicine with AI-enabled diagnostics.
Before the market closed Innovaccer said it raised $275 million in a Series F funding round. Investors included B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente and M12.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
January 09, 2025 16:47 ET (21:47 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments